Skip to content

Medical-device intelligence

Tyson Bioresearch, Inc.: FDA clearances and recalls

Research Tyson Bioresearch, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

13 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jun 16, 2006 to Nov 30, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NBW · System, Test, Blood Glucose, Over The Counter130

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
Tyson Bio HS100 Blood Glucose Monitoring System, Tyson Bio HS100-B Blood Glucose Monitoring SystemK182046 · NBWTyson Bioresearch, Inc.510(k)Nov 30, 2018FDA decision date
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring SystemK182047 · NBWTyson Bioresearch, Inc.510(k)Nov 29, 2018FDA decision date
Tyson Bio HT100 Blood Glucose Monitoring System, Tyson Bio HT100-B Blood Glucose Monitoring SystemK170079 · NBWTyson Bioresearch, Inc.510(k)Oct 6, 2017FDA decision date
TYSONBIO AC500, AC800 BLOOD GLUCOSE MONITORING SYSTEM, TYSONBIO AC500 AC800 PRO BLOOD GLUCOSE MONITORING SYSTEMK123087 · NBWTyson Bioresearch, Inc.510(k)Jun 18, 2013FDA decision date
TYSONBIO MD100 BLOOD GLUCSE MONITORING ,TYSONBIO MD100 PRO BLOOD GLUCISE MONITORING SYSTEMK112916 · NBWTyson Bioresearch, Inc.510(k)Aug 21, 2012FDA decision date
TYSONBIO BLOOD GLUCOSE MONITORING SYSTEM, MODELS AC100 AND AC200K101543 · NBWTyson Bioresearch, Inc.510(k)Aug 30, 2011FDA decision date
EASY STEP AND DIACHEX+ PRO BLOOD GLUCOSE MONITORING SYSTEMSK090629 · NBWTyson Bioresearch, Inc.510(k)Jun 4, 2009FDA decision date
TYSONBIO LINK HEALTH MANAGEMENT SYSTEMK081726 · NBWTyson Bioresearch, Inc.510(k)Aug 26, 2008FDA decision date
DIACHEX BASIC BLOOD GLUCOSE MONITORING SYSTEM, DIACHEX SUPERB BLOOD GLUCOSE MONITORING SYSTEMK072854 · NBWTyson Bioresearch, Inc.510(k)Jun 30, 2008FDA decision date
DIACHEX+DETERMINE BLOOD GLUCOSE MONITORING SYSTEM, DIACHEX-INFINITY BLOOD GLUCOSE MONITORING SYSTEMK073492 · NBWTyson Bioresearch, Inc.510(k)Apr 8, 2008FDA decision date
EZ SCAN PLUS BLOOD GLUCOSE MONITORING SYSTEMK072441 · NBWTyson Bioresearch, Inc.510(k)Mar 25, 2008FDA decision date
DIACHEX BLOOD GLUCOSE MONITORING SYSTEMK062829 · NBWTyson Bioresearch, Inc.510(k)Oct 10, 2006FDA decision date
EZ SMART-168 GLUCOSE MONITORING SYSTEMK052818 · NBWTyson Bioresearch, Inc.510(k)Jun 16, 2006FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗